ANO1 dysfunction has been strongly implicated in several pathological conditions, including asthma (24) and hypertension (25), and has been shown to promote tumor cell proliferation and metastasis in various malignancies, including head and neck squamous cell carcinoma (26), breast cancer (27), and gastric cancer (28). This evidence concerns the gene ANO1 and breast carcinoma.